Friedrich W. Kreth
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming.
Journal: EMBO molecular medicine
Published: March 24, 2021
Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 08, 2019
Outcome in unresectable glioblastoma: MGMT promoter methylation makes the difference.
Journal: Journal of neurology
Published: October 28, 2016
Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma.
Journal: Journal of neuro-oncology
Published: July 26, 2016
Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.
Journal: Cancer medicine
Published: August 03, 2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
Journal: Neurology
Published: January 23, 2015
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients.
Journal: Acta neurochirurgica
Published: January 16, 2014
[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma.
Journal: Molecular imaging
Published: March 16, 2013
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing.
Journal: Acta neuropathologica
Published: September 18, 2012
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
Journal: European journal of nuclear medicine and molecular imaging
Published: October 15, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026